Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABATACEPT Cause C-reactive protein increased? 3,451 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 3,451 reports of C-reactive protein increased have been filed in association with ABATACEPT (ORENCIA). This represents 3.0% of all adverse event reports for ABATACEPT.

3,451
Reports of C-reactive protein increased with ABATACEPT
3.0%
of all ABATACEPT reports
1,016
Deaths
2,027
Hospitalizations

How Dangerous Is C-reactive protein increased From ABATACEPT?

Of the 3,451 reports, 1,016 (29.4%) resulted in death, 2,027 (58.7%) required hospitalization, and 1,103 (32.0%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 3,451 reports have been filed with the FAERS database.

What Other Side Effects Does ABATACEPT Cause?

Drug ineffective (35,212) Rheumatoid arthritis (21,898) Pain (19,783) Arthralgia (18,536) Joint swelling (18,453) Contraindicated product administered (13,559) Fatigue (13,087) Drug intolerance (12,451) Rash (12,168) Arthropathy (11,099)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) SULFASALAZINE (3,096) PREDNISONE (2,363)

Which ABATACEPT Alternatives Have Lower C-reactive protein increased Risk?

ABATACEPT vs ABATACEPT SUBQ /ML ABATACEPT vs ABCIXIMAB ABATACEPT vs ABEMACICLIB ABATACEPT vs ABILIFY ABATACEPT vs ABIRATERONE

Related Pages

ABATACEPT Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased ABATACEPT Demographics